XML 61 R12.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Equity - USD ($)
$ in Millions
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Loss
Unearned ESOP Shares [Member]
The Dow Chemical Company [Domain]
The Dow Chemical Company [Domain]
Common Stock [Member]
The Dow Chemical Company [Domain]
Additional Paid-in Capital [Member]
The Dow Chemical Company [Domain]
Retained Earnings [Member]
The Dow Chemical Company [Domain]
Accumulated Other Comprehensive Loss
The Dow Chemical Company [Domain]
Unearned ESOP Shares [Member]
The Dow Chemical Company [Domain]
Noncontrolling Interests
DowDuPont [Member]
Retained Earnings [Member]
Dow Inc. [Member]
Retained Earnings [Member]
Total Equity, Beginning at Dec. 31, 2018   $ 0 $ 7,042 $ 35,460 $ (9,885) $ (134)   $ 0 $ 7,042 $ 35,460 $ (9,885) $ (134)      
Stock Issued                 0            
Stock-based compensation and allocation of ESOP shares     83     29     83     29      
Stock Issued During Period, Value, Parent Company Stock - DWDP     28           28            
Net income available for The Dow Chemical Company common stockholder       556           556          
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees       (535)                   $ (535) $ 0
Transfer of Business Under Common Control $ 36     35     $ (36)     35          
Other       2           (2)          
Other comprehensive income 102       102   102       102        
Total Equity, Ending at Mar. 31, 2019 33,848 0 7,153 35,403 (9,783) (105) 33,848 0 7,153 35,403 (9,783) (105) $ 1,180    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Stockholders' Equity, Period Increase (Decrease) | Adjustments for New Accounting Pronouncement       (111)           (111)          
Total Equity, Beginning at Dec. 31, 2018   0 7,042 35,460 (9,885) (134)   0 7,042 35,460 (9,885) (134)      
Transfer of Business Under Common Control       14,806           16,009          
Total Equity, Ending at Dec. 31, 2019 14,094 8 7,325 17,045 (10,246) (91) 14,862 0 7,333 17,313 (10,246) (91)      
The Dow Chemical Company’s stockholders’ equity 32,668           32,668                
The Dow Chemical Company’s stockholders’ equity 13,541           14,309                
Stock Issued                 16            
Stock-based compensation and allocation of ESOP shares     29     10     29     10      
Stock Issued During Period, Value, Parent Company Stock - DWDP     0           0            
Net income available for The Dow Chemical Company common stockholder       239           239          
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees       0                   $ 0 $ (643)
Transfer of Business Under Common Control 0     0     0     0          
Other       3           (4)          
Other comprehensive income (283)       (283)   (283)       (283)        
Total Equity, Ending at Mar. 31, 2020 13,461 $ 8 $ 7,370 16,763 $ (10,529) $ (81) 14,228 $ 0 $ 7,378 16,905 $ (10,529) $ (81) $ 555    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Stockholders' Equity, Period Increase (Decrease) | Adjustments for New Accounting Pronouncement       $ 0           $ 0          
The Dow Chemical Company’s stockholders’ equity $ 12,906           $ 13,673